PASI responses with biologics similar among white, nonwhite individuals, study findsMarch 12, 2018PsoriasisPsoriatic Arthritis
Study highlights need to investigate psoriasis treatment outcomes in skin of color patientsMarch 9, 2018PsoriasisPsoriatic Arthritis
VIDEO: PPACMAN aims to advance the combined rheum-derm clinic approach in the communityFebruary 27, 2018PsoriasisAutoimmune DiseasesPsoriatic Arthritis
Could guselkumab be a disease-modifying agent in plaque psoriasis?February 25, 2018PsoriasisPsoriatic Arthritis
Ustekinumab quells aortic inflammation in patients with severe psoriasisFebruary 24, 2018PsoriasisPsoriatic Arthritis
Biologics have best chance of achieving PASI 90 in psoriasisFebruary 21, 2018PsoriasisPsoriatic Arthritis
Risankizumab outpaced ustekinumab for complete clearance of plaque psoriasisFebruary 19, 2018PsoriasisPsoriatic Arthritis
CV risk factors go undiagnosed, untreated in many psoriatic patientsFebruary 8, 2018Psoriatic ArthritisPsoriasis
